Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-02

Clinical Trial Update: Meditation for Emotional Numbing in Post-Traumatic Stress Disorder [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating meditation as a potential treatment for emotional numbing in post-traumatic stress disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Emory University | Conditions: Prolonged Post-traumatic Stress Disorder | Phase 1 | Status: COMPLETED